Total pancreatectomy, splenectomy and remnant gastrectomy for invasive intraductal papillary mucinous neoplasm (IPMN) after prior Roux-en-Y gastric bypass.
Joanna T BuchheitIsha JoshiMatthew E DixonJune S PengPublished in: BMJ case reports (2024)
A female patient in her 50s presented with abdominal pain, nausea and jaundice. She had a history of prior Roux-en-Y gastric bypass and her body mass index was 52.5 kg/m 2 Biochemical testing revealed a total bilirubin level of 14.3 mg/dL (normal<1.2 mg/dL) and carbohydrate antigen 19-9 of 38.3 units/mL (normal<36.0 units/mL). CT demonstrated a 3.2 cm pancreatic head mass, biliary and pancreatic duct dilation and cystic replacement of the pancreas. The findings were consistent with a diagnosis of mixed-type intraductal papillary mucinous neoplasm (IPMN) with invasive malignancy. The patient's Roux-en-Y anatomy precluded endoscopic biopsy, and she underwent upfront resection with diagnostic laparoscopy, open total pancreatectomy, splenectomy and remnant gastrectomy with reconstruction. Pathology confirmed T2N1 pancreatic adenocarcinoma, 1/29 lymph nodes positive and diffuse IPMN. She completed adjuvant chemotherapy. IPMNs have malignant potential and upfront surgical resection should be considered without biopsy in the appropriate clinical setting.
Keyphrases
- roux en y gastric bypass
- low grade
- gastric bypass
- weight loss
- ultrasound guided
- obese patients
- body mass index
- abdominal pain
- lymph node
- high grade
- case report
- bariatric surgery
- fine needle aspiration
- computed tomography
- minimally invasive
- physical activity
- clear cell
- contrast enhanced
- early stage
- weight gain
- robot assisted
- optic nerve
- rectal cancer
- human health
- endoscopic submucosal dissection
- neoadjuvant chemotherapy